DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Cytisine is an investigational drug.
There have been 10 clinical trials for Cytisine. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2017.
The most common disease conditions in clinical trials are HIV Infections, Alcohol Drinking, and Inflammation. The leading clinical trial sponsors are Achieve Life Sciences, University of Auckland, New Zealand, and National Institute on Alcohol Abuse and Alcoholism (NIAAA).
There are two hundred and thirty-seven US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Cytisine
|Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting||Harvard Medical School||Phase 3|
|Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting||Massachusetts General Hospital||Phase 3|
|Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting||University of Ljubljana School of Medicine, Slovenia||Phase 3|
Top disease conditions for Cytisine
Top clinical trial sponsors for Cytisine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Cytisine||Start Trial||Methods and compositions for treating infection||UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)||Start Trial|
|Cytisine||Start Trial||Nicotinic attenuation of CNS inflammation and autoimmunity||Dignity Health (San Francisco, CA)||Start Trial|
|Cytisine||Start Trial||Dietary supplements and formulations||Eastern Vision Limited (Wanchai, HK)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Cytisine||World Intellectual Property Organization (WIPO)||2014052836||2032-09-27||Start Trial|
|Cytisine||World Intellectual Property Organization (WIPO)||2010030887||2028-09-11||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|